Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.
Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Thompson CC, et al. Among authors: zarrinpar a. Am J Gastroenterol. 2017 Mar;112(3):447-457. doi: 10.1038/ajg.2016.500. Epub 2016 Dec 6. Am J Gastroenterol. 2017. PMID: 27922026 Free PMC article. Clinical Trial.
High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis.
Kurnool S, Nguyen NH, Proudfoot J, Dulai PS, Boland BS, Vande Casteele N, Evans E, Grunvald EL, Zarrinpar A, Sandborn WJ, Singh S. Kurnool S, et al. Among authors: zarrinpar a. Aliment Pharmacol Ther. 2018 Jun;47(11):1472-1479. doi: 10.1111/apt.14665. Epub 2018 Apr 17. Aliment Pharmacol Ther. 2018. PMID: 29665045 Free PMC article.
Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Singh S, Facciorusso A, Singh AG, Vande Casteele N, Zarrinpar A, Prokop LJ, Grunvald EL, Curtis JR, Sandborn WJ. Singh S, et al. Among authors: zarrinpar a. PLoS One. 2018 May 17;13(5):e0195123. doi: 10.1371/journal.pone.0195123. eCollection 2018. PLoS One. 2018. PMID: 29771924 Free PMC article. Review.
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.
Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R. Allaband C, et al. Among authors: zarrinpar a. Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230. doi: 10.1016/j.cgh.2018.09.017. Epub 2018 Sep 18. Clin Gastroenterol Hepatol. 2019. PMID: 30240894 Free PMC article. Review.
Targeting Dysbiosis for the Treatment of Liver Disease.
Anand G, Zarrinpar A, Loomba R. Anand G, et al. Among authors: zarrinpar a. Semin Liver Dis. 2016 Feb;36(1):37-47. doi: 10.1055/s-0035-1571276. Epub 2016 Feb 12. Semin Liver Dis. 2016. PMID: 26870931 Free PMC article. Review.
162 results